Evasion of innate immune responses by the highly virulent Cryptococcus gattii by altering capsule glucuronoxylomannan structure

Frontiers in Cellular and Infection Microbiology

Volumn 5, Issue JAN, 2016, Pages

  Urai, Makoto ^a   Kaneko, Yukihiro ^a,b   Ueno, Keigo ^a   Okubo, Yoichiro ^c   Aizawa, Tomoko ^d   Fukazawa, Hidesuke ^a   Sugita, Takashi ^e   Ohno, Hideaki ^a,f   Shibuya, Kazutoshi ^c   Kinjo, Yuki ^a   Miyazaki, Yoshitsugu ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NIHON UNIVERSITY   (Japan)

^e MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^f SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Capsule; Cryptococcus gattii; Cryptococcus neoformans; Dendritic cells; Glucuronoxylomannan; Innate immune responses; O acetylation; Structure

Indexed keywords

CD4 ANTIBODY; CD4 ANTIGEN; GLUCURONOXYLOMANNAN; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; POLYSACCHARIDE;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FUNGAL CAPSULE; FUNGAL STRUCTURES; FUNGAL VIRULENCE; INFLAMMATION; INNATE IMMUNITY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; SURVIVAL; ANIMAL; CELL CULTURE; CHEMISTRY; COCULTURE; IMMUNE EVASION; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS); SURVIVAL ANALYSIS; VIRULENCE;

ACETYLATION; ANIMALS; CELLS, CULTURED; COCULTURE TECHNIQUES; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; CYTOKINES; DENDRITIC CELLS; FUNGAL CAPSULES; IMMUNE EVASION; IMMUNITY, INNATE; LUNG; MICE; POLYSACCHARIDES; SURVIVAL ANALYSIS; VIRULENCE;

EID: 85006219370     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2015.00101     Document Type: Article

References (35)

1. BC Centre for Disease Control, An agency of the Provincial Health Services Authority, British Columbia. (2015). British Columbia Annual Summary of Reportable Diseases 2014. Available online at: http://www.bccdc.ca/bccdc/resources/ar2014finalsmall.pdf
2. Bryan, R. A., Zaragoza, O., Zhang, T., Ortiz, G., Casadevall, A., and Dadachova, E. (2005). Radiological studies reveal radial differences in the architecture of the polysaccharide capsule of Cryptococcus neoformans. Eukaryotic Cell 4, 465-475. doi: 10.1128/EC.4.2.465-475.2005
3. Buchanan, K. L., and Murphy, J. W. (1998). What makes Cryptococcus neoformans a pathogen? Emerging Infect. Dis. 4, 71-83. doi: 10.3201/eid0401.980109
4. Cheng, P. Y., Sham, A., and Kronstad, J. W. (2009). Cryptococcus gattii isolates from the British Columbia cryptococcosis outbreak induce less protective inflammation in a murine model of infection than Cryptococcus neoformans. Infect. Immun. 77, 4284-4294. doi: 10.1128/IAI.00628-09
5. Cherniak, R., and Sundstrom, J. B. (1994). Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect. Immun. 62, 1507-1512.
6. Cherniak, R., Valafar, H., Morris, L. C., and Valafar, F. (1998). Cryptococcus neoformans chemotyping by quantitative analysis of 1H nuclear magnetic resonance spectra of glucuronoxylomannans with a computer-simulated artificial neural network. Clin. Diagn. Lab. Immunol. 5, 146-159.
7. Delfino, D., Cianci, L., Lupis, E., Celeste, A., Petrelli, M. L., Curró, F., et al. (1997). Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components. Infect. Immun. 65, 2454-2456.
8. Delfino, D., Cianci, L., Migliardo, M., Mancuso, G., Cusumano, V., Corradini, C., et al. (1996). Tumor necrosis factor-inducing activities of Cryptococcus neoformans components. Infect. Immun. 64, 5199-5204.
9. DuBois, M., Gilles, K. A., Hamilton, J. K., Rebers, P. A., and Smith, F. (1956). Colorimetric method for determination of sugars and related substances. Anal. Chem. 28, 350-356. doi: 10.1021/ac60111a017
10. Ellerbroek, P. M., Lefeber, D. J., van Veghel, R., Scharringa, J., Brouwer, E., Gerwig, G. J., et al. (2004). O-acetylation of cryptococcal capsular glucuronoxylomannan is essential for interference with neutrophil migration. J. Immunol. 173, 7513-7520. doi: 10.4049/jimmunol.173.12.7513
11. Folch, J., Lees, M., and Sloane-Stanley, G. H. (1957). A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497-509.
12. Galanis, E., Hoang, L., Kibsey, P., Morshed, M., and Phillips, P. (2009). Clinical presentation, diagnosis and management of Cryptococcus gattii cases: lessons learned from British Columbia. Can. J. Infect. Dis. Med. Microbiol. 20, 23-28.
13. Galanis, E., MacDougall, L., Kidd, S., Morshed, M., and British Columbia Cryptococcus gattii Working Group. (2010). Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007. Emerging. Infect. Dis. 16, 251-257. doi: 10.3201/eid1602.090900
14. Janbon, G., Himmelreich, U., Moyrand, F., Improvisi, L., and Dromer, F. (2001). Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide. Mol. Microbiol. 42, 453-467. doi: 10.1046/j.1365-2958.2001.02651.x
15. Kawakami, K., Tohyama, M., Xie, Q., and Saito, A. (1996). IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin. Exp. Immunol. 104, 208-214. doi: 10.1046/j.1365-2249.1996.14723.x
16. Kidd, S. E., Hagen, F., Tscharke, R. L., Huynh, M., Bartlett, K. H., Fyfe, M., et al. (2004). A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc. Natl. Acad. Sci. U.S.A. 101, 17258-17263. doi: 10.1073/pnas.0402981101
17. Kozel, T. R., Levitz, S. M., Dromer, F., Gates, M. A., Thorkildson, P., and Janbon, G. (2003). Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains. Infect. Immun. 71, 2868-2875. doi: 10.1128/IAI.71.5.2868-2875.2003
18. Leongson, K., Cousineau-Côté, V., Goupil, M., Aumont, F., Sénéchal, S., Gaboury, L., et al. (2013). Altered immune response differentially enhances susceptibility to Cryptococcus neoformans and Cryptococcus gattii infection in mice expressing the HIV-1 transgene. Infect. Immun. 81, 1100-1113. doi: 10.1128/IAI.01339-12
19. Levitz, S. M., and Specht, C. A. (2006). The molecular basis for the immunogenicity of Cryptococcus neoformans mannoproteins. FEMS Yeast Res. 6, 513-524. doi: 10.1111/j.1567-1364.2006.00071.x
20. Okamoto, K., Hatakeyama, S., Itoyama, S., Nukui, Y., Yoshino, Y., Kitazawa, T., et al. (2010). Cryptococcus gattii genotype VGIIa infection in man, Japan, 2007. Emerg. Infect. Dis. 16, 1155-1157. doi: 10.3201/eid1607.100106
21. Okubo, Y., Wakayama, M., Ohno, H., Yamamoto, S., Tochigi, N., Tanabe, K., et al. (2013). Histopathological study of murine pulmonary cryptococcosis induced by Cryptococcus gattii and Cryptococcus neoformans. Jpn. J. Infect. Dis. 66, 216-221. doi: 10.7883/yoken.66.216
22. Park, B. J., Wannemuehler, K. A., Marston, B. J., Govender, N., Pappas, P. G., and Chiller, T. M. (2009). Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23, 525-530. doi: 10.1097/QAD.0b013e328322ffac
23. Retini, C., Vecchiarelli, A., Monari, C., Tascini, C., Bistoni, F., and Kozel, T. R. (1996). Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils. Infect. Immun. 64, 2897-2903.
24. Sheng, S., and Cherniak, R. (1997). Structure of the 13C-enriched O-deacetylated glucuronoxylomannan of Cryptococcus neoformans serotype A determined by NMR spectroscopy. Carbohydr. Res. 301, 33-40. doi: 10.1016/S0008-6215(97)00084-0
25. Siddiqui, A. A., Shattock, R. J., and Harrison, T. S. (2006). Role of capsule and interleukin-6 in long-term immune control of Cryptococcus neoformans infection by specifically activated human peripheral blood mononuclear cells. Infect. Immun. 74, 5302-5310. doi: 10.1128/IAI.00661-06
26. Staub, A. M. (1965). "Removal of proteins, " in Methods in Carbohydrate Chemistry, Vol. 5, ed R. L. Whistler (New York, NY: Academic Press), 5-6.
27. Turner, S. H., and Cherniak, R. (1991). Glucuronoxylomannan of Cryptococcus neoformans serotype B: structural analysis by gas-liquid chromatography-mass spectrometry and 13C-nuclear magnetic resonance spectroscopy. Carbohydr. Res. 211, 103-116. doi: 10.1016/0008-6215(91)84149-9
28. Ueno, K., Kinjo, Y., Okubo, Y., Aki, K., Urai, M., Kaneko, Y., et al. (2015). Dendritic cell-based immunization ameliorates pulmonary infection with highly virulent Cryptococcus gattii. Infect. Immun. 83, 1577-1586. doi: 10.1128/IAI.02827-14
29. Urai, M., Anzai, H., Ogihara, J., Iwabuchi, N., Harayama, S., Sunairi, M., et al. (2006). Structural analysis of an extracellular polysaccharide produced by Rhodococcus rhodochrous strain S-2. Carbohydr. Res. 341, 766-775. doi: 10.1016/j.carres.2005.12.013
30. Urai, M., Yoshizaki, H., Anzai, H., Ogihara, J., Iwabuchi, N., Harayama, S., et al. (2007). Structural analysis of an acidic, fatty acid ester-bonded extracellular polysaccharide produced by a pristane-assimilating marine bacterium, Rhodococcus erythropolis PR4. Carbohydr. Res. 342, 933-942. doi: 10.1016/j.carres.2007.02.001
31. Vecchiarelli, A., Pietrella, D., Lupo, P., Bistoni, F., McFadden, D. C., and Casadevall, A. (2003). The polysaccharide capsule of Cryptococcus neoformans interferes with human dendritic cell maturation and activation. J. Leukoc. Biol. 74, 370-378. doi: 10.1189/jlb.1002476
32. Walenkamp, A. M., Chaka, W. S., Verheul, A. F., Vaishnav, V. V., Cherniak, R., Coenjaerts, F. E., et al. (1999). Cryptococcus neoformans and its cell wall components induce similar cytokine profiles in human peripheral blood mononuclear cells despite differences in structure. FEMS Immunol. Med. Microbiol. 26, 309-318. doi: 10.1111/j.1574-695X.1999.tb01403.x
33. Yauch, L. E., Lam, J. S., and Levitz, S. M. (2006). Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan. PLoS Pathog. 2:e120. doi: 10.1371/journal.ppat.0020120
34. Young, B. J., and Kozel, T. R. (1993). Effects of strain variation, serotype, and structural modification on kinetics for activation and binding of C3 to Cryptococcus neoformans. Infect. Immun. 61, 2966-2972.
35. Zaragoza, O., Rodrigues, M. L., De Jesus, M., Frases, S., Dadachova, E., and Casadevall, A. (2009). The capsule of the fungal pathogen Cryptococcus neoformans. Adv. Appl. Microbiol. 68, 133-216. doi: 10.1016/S0065-2164(09)01204-0